All Stories

  1. Rethinking regulatory tiers: Medicare real-world evidence shows CAMP outcomes are independent of FDA regulatory classification

    Article • Journal of Wound Care, December 2025, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  2. Real-world outcomes of a placenta-based tissue product versus standard of care for lower extremity diabetic ulcers: a Medicare cohort study

    Article • Journal of Wound Care, November 2025, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  3. Safeguarding access, fiscal responsibility and innovation: a comprehensive reimbursement framework for CAMPs to preserve the Medicare Trust Fund

    Article • Journal of Wound Care, October 2025, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  4. The hidden costs of limiting access: clinical and economic risks of Medicare’s future effective cellular, acellular and matrix-like products (CAMPs) Local Coverage Determination

    Article • Journal of Wound Care, April 2025, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  5. Innovative treatment of diabetic ulcers: combining chemical debridement and xenograft applications: a case study

    Article • Journal of Wound Care, March 2025, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  6. A review of the proposed draft CAMPs LCDs compared to evidence-based medicine: a letter to the MACs for consideration

    Article • Journal of Wound Care, June 2024, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  7. Dehydrated human amnion/chorion membrane to treat venous leg ulcers: a cost-effectiveness analysis

    Article • Journal of Wound Care, March 2024, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  8. Treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers

    Article • Journal of Wound Care, March 2024, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  9. Dehydrated human amnion chorion membrane to treat venous leg ulcers: a cost-effectiveness analysis

    Article • Journal of Wound Care, March 2024, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  10. Current practices using cellular, acelluar and matrix-like products (CAMPs)

    Article • British Journal of Nursing, February 2024, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  11. Treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers

    Article • Journal of Wound Care, November 2023, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  12. Dehydrated human amnion/chorion membrane use in emergent craniectomies shows minimal dural adhesions

    Article • Journal of Wound Care, October 2023, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  13. Deep palm burn treated with enzymatic debridement followed by autologous skin cell suspension

    Article • Journal of Wound Care, October 2023, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  14. Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs)

    Article • Journal of Wound Care, April 2023, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  15. Pyoderma gangrenosum and dehydrated human amnion/chorion membrane: a potential tool for an orphan disease

    Article • Journal of Wound Care, October 2022, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  16. Outcomes for Medicare debridement intervals receiving dehydrated human amnion/chorion membrane

    Article • Journal of Wound Care, October 2022, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  17. The influence of adequate debridement and placental-derived allografts on diabetic foot ulcers

    Article • Journal of Wound Care, September 2022, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  18. Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment

    Article • Journal of Wound Care, February 2022, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  19. Expandable Dehydrated Human Umbilical Cord Allograft for the Management of Nonhealing Lower Extremity Wounds in Patients With Diabetes: A Case Series

    Article • WOUNDS A Compendium of Clinical Research and Practice, January 2022, HMP Communications, LLC

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  20. Limb Salvage Using Human Placental Allografts: Adding to the Reconstructive Ladder Paradigm

    Article • Surgical Science, January 2022, Scientific Research Publishing, Inc,

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  21. Observed impact of skin substitutes in lower extremity diabetic ulcers: lessons from the Medicare Database (2015–2018)

    Article • Journal of Wound Care, July 2021, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  22. Unique closure of an open fracture complicated with a hard-to-heal lower extremity wound

    Article • Journal of Wound Care, February 2021, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  23. Complex Limb Salvage with Placental-Based Allografts: A Pilot Study

    Article • Surgical Science, January 2021, Scientific Research Publishing, Inc,

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  24. TIMERS: expanding wound care beyond the focus of the wound

    Article • British Journal of Nursing, November 2019, Mark Allen Group

    Mrs Leanne J Atkin, William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  25. The use of placental derived membrane allograft on infected ruptured AV fistula revision and closure

    Article • Journal of Wound Care, October 2019, Mark Allen Group

    Mutaz Fakhry Al-Khateeb, William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  26. Variations in study outcomes relative to intention‐to‐treat and per‐protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft

    Article • International Wound Journal, March 2019, Wiley

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  27. Implementing TIMERS: the race against hard-to-heal wounds

    Article • Journal of Wound Care, March 2019, Mark Allen Group

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  28. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers

    Article • International Wound Journal, September 2018, Wiley

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP

  29. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics

    Article • International Wound Journal, August 2018, Wiley

    William H Tettelbach, MD, FACP, FIDSA, FUHM , MAPWCA, CWSP